Billiontoone, Inc. income statement
In fiscal 2025, Billiontoone, Inc. reported revenue of $305m, up 100.0% on the year before, operating income of $16.0m (a 5.3% margin) and net income of $7.5m, or $0.14 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|
| Revenue | 72 | 153 | 305 | 397 |
| Cost of revenue | 54 | 72 | 97 | 114 |
| Gross profit | 17 | 81 | 208 | 283 |
| Research and development | 22 | 37 | 49 | 59 |
| Selling, general and administrative | 64 | 91 | 143 | 181 |
| Operating income | −69 | −47 | 16 | 43 |
| Interest expense | 3 | 2 | 0 | 0 |
| Income before tax | −83 | −42 | 8 | 38 |
| Income tax | 0 | 0 | 0 | 0 |
| Net income | −83 | −42 | 7 | 38 |
| Diluted EPS | −$4.22 | −$2.06 | $0.14 | — |
| Diluted shares (average) | 20m | 20m | 21m | — |
| EBITDA | −64 | −40 | 23 | 50 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 38 | 45 | 59 | 67 | 84 | 96 | 108 | 109 |
| Cost of revenue | 18 | 19 | 21 | 23 | 25 | 27 | 29 | 32 |
| Gross profit | 20 | 26 | 38 | 43 | 58 | 69 | 79 | 77 |
| Research and development | 10 | 11 | 10 | 12 | 13 | 14 | 15 | 17 |
| Selling, general and administrative | 23 | 26 | 30 | 33 | 36 | 44 | 47 | 54 |
| Operating income | −13 | −12 | −2 | −2 | 10 | 10 | 18 | 6 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before tax | −15 | −11 | −4 | −0 | 6 | 6 | 19 | 8 |
| Income tax | 0 | 0 | 0 | 0 | −0 | 0 | 1 | −1 |
| Net income | −15 | −11 | −4 | −0 | 6 | 6 | 18 | 8 |
| Diluted EPS | −$1.47 | −$1.13 | −$0.39 | −$0.02 | $0.10 | $0.11 | $0.34 | $0.15 |
| EBITDA | — | −10 | −1 | 0 | 11 | 12 | 20 | 7 |
Compare with peers
- Twist Bioscience Corp income statement
- Castle Biosciences Inc income statement
- Fulgent Genetics, Inc. income statement
- Veracyte, Inc. income statement
- Schrodinger, Inc. income statement
Head to head: BLLN vs TWSTBLLN vs CSTLBLLN vs FLGT
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies